Exit this survey >> OD, Pre-Test: Module 2: Polycystic Ovarian Syndrome (PCOS) 1. On-Demand Webinar - Pre Test Question Title Please take a minute to complete this pre-session survey to help ARHP assess the impact of its educational programs. Completing this survey will provide ARHP with an invaluable tool for understanding how health professionals use educational offerings and how ARHP activities might be improved to serve you better. Question Title * 1. Today's Date: Enter today's date Date Question Title * 2. Your primary professional category (choose the one best response): Health Professional Educator Nurse Midwife Nurse Practitioner Pharmacist Physician Physician Assistant Registered Nurse Resident Student Other (please specify) Question Title * 3. Do you interact with patients? Yes No Question Title * 4. Which of the following is a true statement regarding polycystic ovarian syndrome (PCOS)? When selecting a progestin-containing contraceptive for a woman with PCOS, providers should select a progestin with greater androgenic activity. Women with PCOS are at greater risk for endometrial hyperplasia and carcinoma. Combined oral contraceptives are associated with weight gain and should be avoided in women with PCOS. All of the above Question Title * 5. Which of the following is a true statement? The presence of ovarian cysts on ultrasound is sufficient criterion on its own to make a diagnosis of PCOS. Metformin is teratogenic and must be discontinued before attempting conception. Women with obesity and oligomenorrhea must lose at least 15% of their body weight to improve the regularity of their menstrual cycle. All of the above None of the above Question Title * 6. As a result of participating in this activity, I hope to be better able to: Next >>